Carcinoembryonic Antigen (CEA) Industry Survey, Worldwide Trends, Outlook, Overview and 2027 Forecast

About Carcinoembryonic Antigen (CEA):

CEA stands for Carcinoembryonic antigen. CEA is a form of glycoprotein molecule that is generated by cells of the gastrointestinal tract during embryonic development. It is produced in very small quantity after birth. The level of CEA in the bloodstream is thus relatively low unless certain diseases – including certain forms of cancer – are present. Carcinoembryonic antigen (CEA) portrays an arrangement of highly related glycoproteins involved in cell attachment. CEA is normally present just at low levels in the blood of healthy adults. In any case, If the serum levels are brought up in some type of cancer, which implies that it can be used as a tumor maker in clinical tests. Serum levels can likewise be raised in overwhelming smokers. CEA are glycosyl phosphatidyl inositol (GPI) cell surface anchored glycoproteins whose specific sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be important to the metastatic dissemination of colon carcinoma cells. Immunologically they are portrayed as individuals from the CD66 cluster of differentiation

A normal level of CEA is equal to or less than 3 nanograms per milliliter (ng/mL). Most healthy adults have levels below this amount. CEA levels will generally return to normal between one and four months after cancer has been successfully removed from a patients system.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/772

Major Market Players:

  • Roche Diagnostics
  • Quest Diagnostics
  • Correlogic Systems Inc.
  • GenWay Biotech Inc.

Regional Analysis:

North America

Carcinoembryonic Antigen (CEA) market for North America is one of the biggest markets in the globe the main reason behind this is the Cancer rate in the North American countries. Cancer usually develops in older people 86% of all cancers in the United States are diagnosed in people 50 years of age or older.

Typical behaviors also increase the risk of being diagnosed by cancer, these include eating unhealthy diet, heavy smocking or not being physically active. According to cancer facts and figures 2016 US, in a life time the probable risk of developing cancer in men in 42%, one in two men and for women it is 38% that is one in three women. It is estimated that 16,85,210 new cancer case are found in the US every year out of which 5,95,690 have ended up in deaths. With the rate of growth cancer is facing it can easily be estimated that the amount of test taken to diagnose cancer will increase, out of which one test is Carcinoembryonic Antigen (CEA) test. Hence this market will gain huge demand and is expect to grow at a very high growth rate.

Europe

Europe is the second largest market for Carcinoembryonic Antigen (CEA). This is also because the high growth rate of cancer in Europe. Most cancers are related to lifestyle, behavioral or environmental exposures. The term environmental is used by cancer experts because it refers to everything outside the body that is being interacted with humans. in this sense, the environment is not limited to the biophysical environment(pollution, air, sunlight etc) it also includes lifestyle behavior factors, common behavior factors that lead to cancer is tobacco, diet, obesity, radiation, stress and environmental pollutions. As per FACE in 2009 all European countries had 2,333,407 number of new cancers cases and is expect to grow to 2,660,561 in 2020 with a percentage increase of 14.0. with this growth rate the market for Carcinoembryonic Antigen (CEA) tests will increase and it will face tremendous growth in the coming future.

The reports also covers brief analysis of Geographical Region includes:

Americas

  • North America
  • US
  • Canada
  • Mexico
  • Latin America

Europe

  • Western Europe
  • Germany
  • France
  • Italy
  • Spain
  • K
  • Rest of Western Europe
  • Eastern Europe

Asia– Pacific

  • Asia
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia
  • Pacific Countries
  • The Middle East& Africa

The common reasons other than cancer for the growth of Carcinoembryonic antigen CEA are

  • Cirrhosis of the liver
  • Inflammatory bowel disease
  • Heavy smoking
  • Infection

Browse Report Details @

https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market

Carcinoembryonic Antigen (CEA) test Application

A CEA test is most useful if you’ve been diagnosed with a type of cancer, which is known to produce CEA. Not all types of cancers produce CEA. Increased levels of CEA may be found in the following cancers:

  • breast cancer
  • lung cancer
  • prostate cancer
  • liver cancer
  • colorectal cancer
  • pancreatic cancer
  • Thyroid cancer
  • Others

Market growth driver:

With the diagnosis of different types of cancers in the globe, Carcinoembryonic Antigen (CEA) test helps the doctor to diagnose and find out the type of cancer present in the patient’s body. With this unique quality CEA tests demand and market will be in huge demand and this market will be highly lucrative.

Every report of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report also gives a broad study of the different market segments and regions.

Request Table of Contents for This Report @ https://www.marketresearchfuture.com/request-toc/772

Continue…

We are thankful for the support and assistance from “Carcinoembryonic Antigen (CEA) Market- Forecast to 2027chain related technical experts and marketing experts during Research Team survey and interviews.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various

Industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw

Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

 

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: